stockrowInflaRx N.V. (IFRX) vs Keros Therapeutics, Inc. (KROS)
- InflaRx N.V. IFRX 1.31 −3.68%
- Keros Therapeutics, Inc. KROS 9.36 −0.95%
InflaRx N.V. and Keros Therapeutics, Inc. are both Biotechnology companies. InflaRx N.V. and Keros Therapeutics, Inc. are of similar size ($192.3M and $183.7M). Keros Therapeutics, Inc. grew revenue faster over the last twelve months: −76.4% against −83.4%. InflaRx N.V. has the higher net margin (0.00% vs −112.2%) and the higher return on invested capital (−87.3% vs −233.2%). Across the 16 metrics below, Keros Therapeutics, Inc. leads on 10 and InflaRx N.V. on 6.
Valuation
Profitability
| Metric | IFRX | KROS | Biotechnology median |
|---|---|---|---|
| Gross margin | (26,762.42%) | 100.00% | 68.51% |
| Operating margin | 0.00% | (133.16%) | 0.00% |
| Net margin | 0.00% | (112.18%) | 0.00% |
| Free cash flow margin | 0.00% | (87.73%) | 0.00% |
| Return on equity | (30.98%) | (12.56%) | (51.96%) |
| Return on assets | (25.90%) | (11.76%) | (46.06%) |
| Return on invested capital | (87.31%) | (233.22%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack